Evidence map›Paper›PMID 20670606›Full record

ReviewMethods (San Diego, Calif.)2011

In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus.

Leonard Chávez, Steven Kauder, Eric Verdin

Abstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Examining the Impact of Galectin-9 on Latent HIV Transcription.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Review
  10. Article
  11. Review
  12. Single cell epigenetic visualization assay.Nucleic acids research · 2021
    Article
  13. Article
  14. Deciphering DNA Methylation in HIV Infection.Frontiers in immunology · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Block and Lock HIV Cure Strategies to Control the Latent Reservoir.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Leonard ChávezGladstone Institute of Virology and Immunology, University of California, San Francisco, 1650 Owens Street, CA 94158-2261, USA. leonard.chavez@ucsf.edu
Steven Kauder
Eric Verdin
University of California, San Francisco · US

Funding

Maximizing Opportunities for Research Excellence - Evaluation Training SupplementR25GM056847 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUNCAN, D'ANNE S., SELLO, JASON K · 1998 to 2023
$14.1M
Epigenetic regulation of HIV latencyR01DA030216 · NIDA · J. DAVID GLADSTONE INSTITUTES · PI VERDIN, ERIC M. · 2010 to 2014
$2.6M
NIDA NIH HHS R01 DA030216NIGMS NIH HHS R25 GM056847NIGMS NIH HHS R25-GM56847
6 · The paper itself

Abstract

HIV-1 latency is a barrier to overcome in the effort to fully eradicate the virus from infected individuals using highly active anti-retroviral therapy (HAART). Therefore, the study of the mechanisms underlying the establishment and maintenance of HIV-1 latency are vital to achieving a cure. Transcriptional repression of the viral promoter is the major cause of HIV-1 latency. DNA methylation of genomic regions known as CpG islands (CpGIs) is a well-established transcriptional regulatory mechanism, and the HIV-1 provirus contains several conserved CpGIs including two that are located within the viral promoter region. The study of these CpGIs in both in vitro and in vivo models of HIV-1 latency using the technique of bisulfite-mediated methylcytosine mapping has led to their identification as factors that contribute to the maintenance of HIV-1 latency. Here, we discuss the identification of CpGIs within the HIV-1 provirus and the study of their differential methylation patterns in several HIV-1 latency models using bisulfite-mediated methylcytosine mapping.

Indexed as

Genome, Viral5-MethylcytosineBase SequenceCloning, MolecularComputer SimulationCpG IslandsDNA MethylationDNA, ViralHIV-1HIV InfectionsHumansModels, GeneticProvirusesSulfitesVirus IntegrationVirus Latency5-MethylcytosineDNA, Viralhydrogen sulfiteSulfites

Identifiers

PMID20670606
PMCPMC3566233
OpenAlexW2090563308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.